Nominations are open for 2027 ASH committee and leadership positions! Step forward or recommend a colleague to help shape #hematology initiatives, support research, and bring new perspectives to the Society. 🔗 Submit your nomination now: https://ow.ly/WOYa50Y7Fci#hematology #HemeSky #MedSky

Last few days of Early Bird Pricing for #MYELOID2026! HOME - FIFTEENTH INTERNATIONAL WORKSHOP ON MOLECULAR ASPECTS OF MYELOID STEM CELL DEVELOPMENT AND LEUKEMIA share.google/jz1xtCvtDhn9...

You don’t need a brain to benefit from a good night of sleep. Despite lacking a central nervous system, jellyfish and sea anemones have sleep patterns remarkably similar to those of humans, researchers report. Learn more: https://scim.ag/3NgeAEQ

Nature research paper: Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit go.nature.com/45m7t4b

Now online in Cancer Discovery @aacrjournals.bsky.social: Genotype-to-Phenotype Mapping of Somatic Clonal Mosaicism via Single-Cell Co-Capture of DNA Mutations & mRNA Transcripts by @dennisjyuan.bsky.social, @landau.bsky.social, et al. doi.org/10.1158/2159... @nygenome.org @weillcornell.bsky.social

We're excited to share that Blood Advances has a new Associate Editor, Dr. Steven Lane. He's a clinical hematologist and researcher at Royal Brisbane & Women's Hospital and runs a busy research group at the Queensland Institute of Medical Research. Welcome Dr. Lane! #BloodAdvances

The MPN Challenge™ funding cycle is now open. Find further details on eligibility, proposal guidelines, and deadlines. https://goto.mpnresearchfoundation.org/49ixqCH. Proposals are due by March 23, 2026 at 11:59PM CT. #2026MPNChallenge #MPNChallenge #RFA #MPNFundingOpportunity #MPNRF

Papers submitted on Tuesdays are more likely to be accepted by Nature whereas Wednesdays seem the most likely day to submit and secure acceptance to PLOS ONE. For Cell, Mondays and Tuesdays seem the best submission days in case of accepted papers. link.springer.com/article/10.1...

Fascinating study on Anna’s hummingbird, one of the many beautiful birds I frequently see on the Stanford campus! 🐦 @stanforduniversity.bsky.social

Excited to kick off 2026 with a #Hematology seminar from Arun Wiita, MD, PhD on Jan 8th! Arun has pioneered proteomics to characterize aberrantly expressed cell surface proteins in #bloodcancers, to identify novel targets for #immunotherapy, looking forward to this! @stanforddeptmed.bsky.social

Coming next week on The Future of Medicine: Jennifer Doudna, a Nobel Prize–winning biochemist & the co-inventor of CRISPR gene editing! #StanDOM's @euanashley.bsky.social#StanDOM& Doudna discuss scientific curiosity, responsible innovation, gene editing & more. https://bit.ly/43LGRZv

At a recent #MedicineGrandRounds, @childrensphila.bsky.social's Alexis Thompson discussed her groundbreaking research on #SickleCellDisease. Her clinical research was instrumental in the approval of the first gene therapies for sickle cell disease. 📸 by Clinton Louie

Today's the print release of a #RibackLab and #GoodellLab collaboration— we’re excited to share the visual story behind the science, including the dramatic artwork that inspired how we thought about aberrant function of NPM1c - which occurs in about 1 in 3 adult acute myeloid leukemias (#AML).

One of my favorite pics of the Myeloid Workshop at #ASH2025. Not at all challenging to find female speakers; thanks to ASH and the excellent section leaders for making this happen!

The gavel has officially passed at #ASH25. Thank you, Dr. Avalos, for your outstanding leadership. And welcome to Dr. Robert Negrin, whose dedication to mentorship, discovery, and advancing hematology will continue to strengthen the field.

There’s an art to writing a grant proposal so that your creativity is on full display. Maria Leptin - president of the ERC - talks about it on the new episode of the Night Science Podcast.

Such a great event! #ASH25

Lachelle Weeks, MD, PhD, shares findings that demonstrate sickle cell disease may predispose patients to high-risk clonal hematopoiesis. This multinational cohort defined CH prevalence, age distribution, and mutational profiles in SCD relative to non‐SCD controls and other hemoglobinopathies. #ASH25

EBV & Lupus — A Breakthrough Publication of 2025 Announced in Nov. 2025, a landmark Science Translational Medicine study from #StanDOM's William H. Robinson revealed how the common Epstein-Barr virus can infect & reprogram immune cells to trigger lupus. https://stanford.io/3LUx3Gg

“I had hemophilia for nearly five decades. I went to Philadelphia and had a 45-minute infusion, and my hemophilia was gone.” Genes-> Medicine nature.com/articles/s41...

Ah, how I miss New England! 🥶 🤣

Looking forward to this session #ASH25 @ash.hematology.org @vangalenlab.bsky.social

Very interesting! 🧬

Here's your first look at The Future of Medicine, our new #StanDOM podcast launching Dec. 1! Meet host @euanashley.bsky.social & hear more about the exciting paths we will chart together! Subscribe anywhere you listen to podcasts or watch on YouTube at https://bit.ly/44vtyMX

The highly anticipated #ASH25 late-breaking abstracts have been posted: https://ow.ly/EGCi50XwYbf#ASH25 👏 #ASHKudos to the presenters! Discover more important and novel research at the 67th ASH Annual Meeting. It's not too late to register! #Hemesky #Medsky

This was an amazing MGR presentation! @stanforddeptmed.bsky.social

Interesting, congrats! #MajetiLab @stanfordmedicine.bsky.social

If you have not read this moving and courageous essay from Tatiana Schlossberg in the @newyorker.com, please check it out. You may be wondering why inv(3) leukemia is so deadly? Here is a brief 🧵 (1/n)

Tatiana Schlossberg, the daughter of Caroline Kennedy, had just given birth when she was diagnosed with a rare form of leukemia. She writes about her fear of adding another tragedy to her family’s life. https://newyorkermag.visitlink.me/CLpbsb

Very cool! @stanforddeptmed.bsky.social

Amazing! @ash.hematology.org

Delighted to welcome Dr. Fred Appelbaum from #FHCRC to Stanford #Hematology today! A giant in #bloodcancers, a superb #physicianscientist & recently an author of the fab book #LivingMedicine, a history of Dr. Don Thomas, marrow transplant & #celltherapy, a great read! @stanforddeptmed.bsky.social

Fun times at #Stanford DOM, awesome community! @stanforddeptmed.bsky.social

Our own, Prof. Larry Leung is this month’s #Hematology Breakthroughs speaker! A former #Stanford Division Chief of Hematology, Larry’s lab studies the basic biology of thrombosis/hemostasis. He will discuss all things #thrombin, promises to be a great seminar, Oct 16! 👇🏽 @stanforddeptmed.bsky.social

If you've been meaning to check out the Night Science Podcast, this is the perfect episode to get started with. Everyone is telling me it's our best one yet!

Very interesting, congrats! 🎊🎉

Interested in PhD in CRISPR engineering to develop new models of myeloid malignancies?! Join me @cruk-mi.bsky.social www.crukcentre.manchester.ac.uk/opportunitie... For Clinically trained applicants-DM if you have queries Deadline 17th November 2025

Pretty awesome to have Nobel Laureate, Prof. Jennifer Doudna as our Medical Grand Rounds speaker today! #CRISPR @stanforddeptmed.bsky.social

A @stanfordmedicine.bsky.social clinical trial, led by #StanDOM's Jason Gotlib, results in FDA approval of a new treatment for a rare, deadly blood cancer. https://stan.md/4mXxtti

Enjoyed this interview! One of several takeaways: Constructive scientific criticism is a form of respect i.e. indicates your science matters!

Just add students, a new academic year begins! @stanforduniversity.bsky.social

Congratulations Lucy Shapiro @stanfordmedicine.bsky.social med.stanford.edu/news/all-new...

Happening today at noon! 👇🏽

David Baltimore, in his own words (2019).

David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87 www.nytimes.com/2025/09/07/s...

Excited to kick off a new year of Stanford #Hematology Breakthroughs seminars! We start w/ Prof. Lucy Godley from Northwestern Feinberg SOM speaking on germline predisposition to heme malignancies, a topic on which she has immense expertise, promises to be a great seminar, next week! 👇🏽

Excited to share our discovery of potent TRIM21 molecular glues with anticancer activity, online today @CD_AACR: "Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complex". 1/18

Please check out this thread on our latest paper in @nature.com on HSC pool size regulation. rdcu.be/eCJLe Phenomenal collaboration with @gritsmanlab.bsky.social, and driven by the outstanding Shoichiro Takeishi! @einsteincellbio.bsky.social @einsteinmededu.bsky.social (1/6)

Platelets sequester and harbor cell-free tumor DNA, which could enhance our ability to make early, microscopic diagnosis of cancer @science.org science.org/doi/10.1126/... science.org/doi/10.1126/...

Rescheduled & happening today at noon! 👇🏽